| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 07/10/2003 | US20030129734 Copper tolerant yeast and pectinases produced by the yeast |
| 07/10/2003 | US20030129733 Inactivated genomes of diploid microorganisms which are inducible into haploid forms; drug screening |
| 07/10/2003 | US20030129718 Amylase variants |
| 07/10/2003 | US20030129714 Reacting an aldehyde or ketone with a carbonic acid nitrile to form a 1-cyanoalkyl carbonate |
| 07/10/2003 | US20030129713 Reacting the ketals or acetals with a cyanide donor in the presence of an (R)- or (S)- hydroxynitrile lyase |
| 07/10/2003 | US20030129702 DNA encoding galanin GALR2 receptors and uses thereof |
| 07/10/2003 | US20030129636 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| 07/10/2003 | US20030129635 Polynucleotide comprising the complete aveC ORF of S. avermitilis, that lacks the next complete ORF that is located downstream from the aveC ORF in situ in the S. avermitilis chromosome. |
| 07/10/2003 | US20030129586 Contains amino acid motifs of a serine proteinase, a nucleotide triphosphatase (NTPase), and an RNA helicase. |
| 07/10/2003 | US20030129582 Method for determining early HCV seroconversion |
| 07/10/2003 | US20030129202 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof |
| 07/10/2003 | US20030129197 Influenza vaccine |
| 07/10/2003 | US20030129184 Monoclonal antibody specific to polypeptide which induces interferon-gamma production |
| 07/10/2003 | CA2472401A1 Improved method of production of lycopene by the fermentation of selected strains of blakeslea trispora, formulations and uses of the lycopene obtained |
| 07/10/2003 | CA2471131A1 An avian embryo particulate biomass for the production of virus antigens |
| 07/10/2003 | CA2468081A1 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 07/10/2003 | CA2457801A1 Streptococcus thermophilus strain and use thereof |
| 07/09/2003 | EP1325957A2 Recombinant papilloma virus L1 |
| 07/09/2003 | EP1325953A1 Method of culturing mesenchymal stem cells |
| 07/09/2003 | EP1325030A2 Genes isolated from dendritic cells, gene products and methods employing the same |
| 07/09/2003 | EP1324980A1 Citrullimycines, a process for their production and their use as pharmaceuticals |
| 07/09/2003 | EP1324736A2 Rapid antibiotic susceptibility test |
| 07/09/2003 | EP1112081A4 USE OF mCRP TO SLOW CELL GROWTH AND TO PROMOTE MATURATION OF CELLS |
| 07/09/2003 | EP0975326B1 Topical application of enzymes using a peelable film |
| 07/09/2003 | EP0939831B1 Novel bacterial strains and use thereof in fermentation processes for 2-keto-l-gulonic acid production |
| 07/09/2003 | EP0781843B1 Novel strain of the yeast candida sake (saito and ota) van uden and buckley and its use as biological control agent in fungal diseases of postharversted fruits |
| 07/09/2003 | EP0686194B1 Harp family growth factors, preparation methods therefor and uses thereof |
| 07/09/2003 | EP0668924B1 HUMANIZED ANTIBODIES TO Fc RECEPTORS FOR IMMUNOGLOBULIN G ON HUMAN MONONUCLEAR PHAGOCYTES |
| 07/09/2003 | EP0511308B2 Chimeric immunoglobulin for cd4 receptors |
| 07/09/2003 | CN1429276A Modulating production of pneumococcal capsular polysaccharide |
| 07/09/2003 | CN1428426A Programmed cell death induction molecule II |
| 07/09/2003 | CN1428417A Miroorganism for over-producing 5'-xanthylic acid |
| 07/09/2003 | CN1428352A Reformed monoclonal antibody for resisting immunoglobulin homoeotype |
| 07/09/2003 | CN1113966C Fermentation method for preparing acabose by osmosis control |
| 07/09/2003 | CN1113965C Process for production of clavulanic acid and/or salts thereof |
| 07/09/2003 | CN1113962C Stress resistant plant in which cell death suppressing gene is introduced and method for producing same |
| 07/09/2003 | CN1113604C Use of streptomyces WYEC 108 to control plant pathogens |
| 07/08/2003 | US6590141 Nucleic acid molecules from plants encoding enzymes which participate in starch synthesis |
| 07/08/2003 | US6589777 Use to prepare enantiomerically pure precursor material for sertraline synthesis - "(4S) tetralone" or 4-(3,4-dichloro-phenyl)-3,4-dihydro-1(2H)-naphthalenone and for subsequent use in preparation of antidepressant and anorectic agents |
| 07/08/2003 | US6589765 Yield of paclitaxel from Taxus cell cultures is increased by optimizing incubation temperature with cell growth stage, by increasing cell inoculum size, and increased level of maltose in the medium; use in improving industrial production |
| 07/08/2003 | US6589732 Transducing phages |
| 07/08/2003 | US6589530 Hepatitis B surface antigen vaccine |
| 07/08/2003 | US6589529 Recombinant fusion proteins as immunogens; VP6 protein or carboxy- terminal fragment |
| 07/08/2003 | CA2133646C Stem cell proliferation factor |
| 07/08/2003 | CA2080920C Cloning by complementation and related processes |
| 07/08/2003 | CA2035384C Preparation and use of gene banks of synthetic human antibodies ("synthetic human-antibody libraries") |
| 07/03/2003 | WO2003054550A2 Uses of an endothelial cell receptor |
| 07/03/2003 | WO2003054204A1 Method for producing highly functional, hyper branched polyester by means of enzymatic esterification |
| 07/03/2003 | WO2003054199A2 Phytases and method for producing these phytases |
| 07/03/2003 | WO2003054185A1 Novel alkaline protease from bacillus gibsonii (dsm 14391) and washing and cleaning agents containing said novel alkaline protease |
| 07/03/2003 | WO2003054184A1 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease |
| 07/03/2003 | WO2003053158A2 Malleable protein matrix and uses thereof |
| 07/03/2003 | US20030125519 Ligand for the c-kit receptor and methods of use thereof |
| 07/03/2003 | US20030124707 Acetamidases for use as reporter gene in cell transformations; homologous recombination; gene replacement therapy |
| 07/03/2003 | US20030124693 Enzymatic conversion of epoxides |
| 07/03/2003 | US20030124691 Method for producing amide compounds |
| 07/03/2003 | US20030124690 Novel compounds |
| 07/03/2003 | US20030124688 Microorganism producing l-lysine and processes for producing l-lysine using the same |
| 07/03/2003 | US20030124675 Isolated CDNA encoding tumor necrosis factor binding protein II, its purification, and vectors, hosts and processes using such cDNA |
| 07/03/2003 | US20030124674 Batch fermentation of polypeptides; cosmetics; foods; medicines |
| 07/03/2003 | US20030124664 Aminopeptidase |
| 07/03/2003 | US20030124655 Receptor protein specifically recognizing bacterial dna |
| 07/03/2003 | US20030124650 Isolating streptomyces serine proteases using immunoaffinity chromatography; oligopeptides |
| 07/03/2003 | US20030124607 Methods related to streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| 07/03/2003 | US20030124578 Assay for detection of human parvovirus B19 nucleic acid |
| 07/03/2003 | US20030124575 Dendritic cells; antigen presenting cells; g-protein coupled receptors; immunotherapy; antiinflammatory agents; antitumor agents; viricides; drug screening |
| 07/03/2003 | US20030124557 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function |
| 07/03/2003 | US20030124546 Fragments of nucleic acids specific to mycobacteria which are members of the M. tuberculosis complex and their applications for the detection and the differential diagnosis of members of the M. tuberculosis complex |
| 07/03/2003 | US20030124538 Reverse two-hybrid systems |
| 07/03/2003 | US20030124517 Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof |
| 07/03/2003 | US20030124169 Biocompatible, biodegradable matrix and a protein, produced by expression of recombinant DNA capable of inducing endochondral bone formation in association with said matrix |
| 07/03/2003 | US20030124105 Programmed cell death genes and proteins |
| 07/03/2003 | CA2471417A1 Uses of an endothelial cell receptor |
| 07/03/2003 | CA2470776A1 Malleable protein matrix and uses thereof |
| 07/03/2003 | CA2467207A1 Novel phytases and method for producing these phytases |
| 07/02/2003 | EP1323832A1 Culture medium and method for identifying gram-negative microorganisms |
| 07/02/2003 | EP1323831A1 Corynebacteria overproducing 5'-xanthylic acid |
| 07/02/2003 | EP1323829A2 Method for the preparation of protected, enantiomerically enriched cyanohydrines by in-situ derivatisation |
| 07/02/2003 | EP1323828A2 Method for the preparation of enantiomerically enriched cyanohydrines using acetals or ketals as substratess |
| 07/02/2003 | EP1323824A2 Use of human keratinocyte growth factor-2 for the preparation of pharmaceutical compositions |
| 07/02/2003 | EP1323428A2 Avirulent Salmonella typhi microbes and uses thereof |
| 07/02/2003 | EP1322775A2 Ethanol production |
| 07/02/2003 | EP1322763A2 Listeria inocua , genome and applications |
| 07/02/2003 | EP1322751A2 Glutaryl cephalosporin amidase from pseudomonas diminuta bs-203 |
| 07/02/2003 | EP1322170A2 A NOVEL STRAIN OF i STREPTOMYCES /i FOR CONTROLLING PLANT DISEASES |
| 07/02/2003 | EP1107662A4 Manipulation of tocopherol levels in transgenic plants |
| 07/02/2003 | EP0900025B1 Moraxella catarrhalis outer membrane protein omp106, gene sequence and uses thereof |
| 07/02/2003 | EP0732875B1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
| 07/02/2003 | CN1427894A Process for preparation of alkaline earth salts of D-pantothnic acid |
| 07/02/2003 | CN1427892A Virulence genes, proteins and their use |
| 07/02/2003 | CN1427888A Method and apparatus for culturing cell or tissue |
| 07/02/2003 | CN1427886A Spray-dried microbial cells |
| 07/02/2003 | CN1427845A Cyclipostins, method for their production and use of same |
| 07/02/2003 | CN1113102C Antitumer preparation |
| 07/02/2003 | CN1113101C Process for preparation of substituted aryl lactic acid containing cyclodepsipeptides with 24 ring atoms |
| 07/02/2003 | CN1113097C Processes for preparation of Marek's disease virus using continuous mammalian cell lines |
| 07/02/2003 | CN1113096C New stromal cell lines from human bone marrow and their use |
| 07/02/2003 | CN1113068C Materials for production of nanometer structure and use thereof |
| 07/02/2003 | CN1112931C Anti-stress drugs and functional foods having anti-stress effects |
| 07/02/2003 | CN1112915C New scleroglucans and cosmetic compositions containing new compounds |